Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one

1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one is listed in the pharmaceutical impurity collection under CAS 52446-73-8. Its represented structure has formula C24H25NO3 and a calculated molecular weight of 375.47 g/mol.

2D chemical structure

N H O H O O

Chemical identity

Catalog name
1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one
Common name
1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one
Chemical name
2-[2-(4-hydroxyphenyl)ethylamino]-1-(4-phenylmethoxyphenyl)propan-1-one
CAS
52446-73-8
SMILES
CC(NCCc1ccc(O)cc1)C(=O)c1ccc(OCc2ccccc2)cc1
InChI
InChI=1S/C24H25NO3/c1-18(25-16-15-19-7-11-22(26)12-8-19)24(27)21-9-13-23(14-10-21)28-17-20-5-3-2-4-6-20/h2-14,18,25-26H,15-17H2,1H3
InChIKey
QKVNQEPGFVLFCE-UHFFFAOYSA-N

Record ID: A6c9e76034890

Computed properties

C24H25NO3 Molecular formula
375.468 g/molMolecular weight
375.1834 DaMonoisotopic exact mass
58.56 ŲTopological polar surface area
4.3747 Calculated LogP (Wildman–Crippen)
110.822 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 9 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight375.46863.83
Calculated LogP (Wildman–Crippen)4.374783.20
Topological polar surface area58.5639.31
Hydrogen-bond acceptors450.68
Hydrogen-bond donors264.87
Rotatable bonds (strict)986.25

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC24H25NO3dimensionless
Molecular weight375.468g/mol
Monoisotopic exact mass375.1834Da
Topological polar surface area58.56Ų
Calculated LogP (Wildman–Crippen)4.3747dimensionless
Molar refractivity (Wildman–Crippen)110.822cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors2count
Rotatable bonds (strict)9count
Heavy atoms28count
Heteroatoms4count
Rings3count
Aromatic rings3count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles3count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.2083fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area165.3544Ų
Valence electrons144count
Radical electrons0count
Bertz complexity873.9885index
Balaban J1.4658index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one

Qualification and safety assessment of 1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one

Explore toxicological qualification of 1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one and ICH M7 mutagenic impurity assessment of 1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one and acceptable intake and limit justification for 1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1-(4-(benzyloxy)phenyl)-2-((4-hydroxyphenethyl)amino)propan-1-one

Explore Altox services and software through the Altox Pharma-Hub.